B

Black Diamond Therapeutics
D

BDTX

3.88000
USD
0.15
(4.02%)
مغلق
حجم التداول
32,366
الربح لكل سهم
0
العائد الربحي
-
P/E
16
حجم السوق
220,908,883
الأخبار المقالات

العنوان: Black Diamond Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.